Mario Cruciani

10.3k citations
178 papers · 7.8k · 2 hit papers · h-index 44

Impact in

    • Antifungal resistance and susceptibility
    • HIV/AIDS drug development and treatment
    • Antimicrobial Resistance in Staphylococcus
    • Tuberculosis Research and Epidemiology
  • Epidemiology top 0.5%
    • Fungal Infections and Studies
    • Pneumocystis jirovecii pneumonia detection and treatment

Papers in

    • HIV/AIDS drug development and treatment 25
    • Antifungal resistance and susceptibility 24
    • Pneumocystis jirovecii pneumonia detection and treatment 23
    • Fungal Infections and Studies 13
    • Pneumonia and Respiratory Infections 11

Mario Cruciani

174 papers receiving 7.4k citations

Mario Cruciani's Hit Papers

COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis 2023 · 103 citations
1030+2+4Years since publication50010001.5k2.0k

Peers

Mario Cruciani
Comparison fields: 5 of 142
  • Infectious Diseases 4.0k
  • Epidemiology 3.0k
  • Applied Microbiology and Biotechnology 133
  • Virology 294
  • Clinical Biochemistry 312
Replace Annelies Verbon with:
Annelies Verbon Netherlands
Jörg Janne Vehreschild Germany
Florence Ader France
Isabel Ruíz-Camps Spain
Peter Speelman Netherlands
P. Chavanet France
Miguel Salavert Lleti Spain
Jesús Fortün Spain
Drew J. Winston United States
Raymund Rabe Razonable United States
Mario Cruciani relative to Annelies Verbon Netherlands Annelies Verbon's profile →
Citations per field
00.5×1.7×
Annelies Verbon · 1×
Citations per year

Countries citing papers authored by Mario Cruciani

Since Specialization
Citations

This map shows the geographic impact of Mario Cruciani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Cruciani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Cruciani more than expected).

Fields of papers citing papers by Mario Cruciani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Cruciani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Cruciani. The network helps show where Mario Cruciani may publish in the future.

Co-authors

The 25 scholars most cited alongside Mario Cruciani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mario Cruciani Line = papers co-authored together Mario Cruciani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Hit paper breakdown →
20192112
2 2009299
3 2011243
4 1996240
5 2004221
6 1996195
7 1999157
8 2006143
9 2011134
10 2017131
11 2018116
12 2007110
13 2005104
14
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Hit paper breakdown →
2023103
15 200292
16 200591
17 200886
18 201184
19 201577
20 200170

About Mario Cruciani

Mario Cruciani is a scholar working on Infectious Diseases, Epidemiology, Virology, Pharmacology and Clinical Biochemistry, having authored 178 papers that have together received 7.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (25 papers), Antifungal resistance and susceptibility (24 papers), Pneumocystis jirovecii pneumonia detection and treatment (23 papers), Fungal Infections and Studies (13 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), HIV Research and Treatment (11 papers), Pneumonia and Respiratory Infections (11 papers) and Bacterial Identification and Susceptibility Testing (10 papers). The work is most often cited by research in Infectious Diseases (4.0k citations), Epidemiology (3.0k citations), Applied Microbiology and Biotechnology (133 citations), Virology (294 citations) and Clinical Biochemistry (312 citations). Mario Cruciani has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Carlo Mengoli, Marina Malena, Giovanni Serpelloni, Massimo Franchini, Oliviero Bosco, Ercole Concia, Dante Bassetti, Giorgio Gatti, Jürgen Löffler and J. Peter Donnelly. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Cochrane Database of Systematic Reviews, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact